Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients

Launched by INSTITUTE OF HEMATOLOGY & BLOOD DISEASES HOSPITAL, CHINA · Jun 24, 2019

Keywords

ClinConnect Summary

This clinical trial is looking at how the immune system changes in patients with a condition called immune thrombocytopenia (ITP) before and after they have surgery to remove their spleen, known as a splenectomy. ITP is a condition where the body doesn't produce enough platelets, which are important for blood clotting. By understanding these changes, researchers hope to learn more about how the body responds to this surgery and improve treatment options for patients with ITP.

To participate in this trial, you need to be between 18 and 60 years old and have been diagnosed with ITP that requires a splenectomy. It’s important that you are willing to follow the study guidelines and give your consent to participate. If you take part, you can expect to be monitored before and after your surgery to see how your immune system reacts. This study is currently recruiting participants, and both men and women are welcome to join.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged 18 to 60 years old, male or female;
• • Conform to the diagnostic criteria of immune Thrombocytopenia (ITP)
• • Needed splenectomy;
• • People who are willing to sign the informed consent voluntarily and follow the research program.
• Exclusion Criteria:
• • Secondary thrombocytopenic purpura;
• • Patients with poor compliance;
• • Researchers believe that patients should not participate in the test of any other condition.